Connect with others who understand.

sign up log in
Resources
About MyMyelomaTeam

Connect with others who understand.

sign up log in
Resources
About MyMyelomaTeam

MGUS and Peripheral Neuropathy

Posted on November 01, 2021
Medically reviewed by
Mark Levin, M.D.
Article written by
Samantha Poorman

Peripheral neuropathy (PN) — weakness, numbness, or pain related to nerve damage — is a common symptom of clonal plasma disorders. Some people with PN experience it as pain, numbness, weakness, or a pins-and-needles sensation. One clonal plasma disorder associated with PN is monoclonal gammopathy of undetermined significance (MGUS).

In clonal plasma disorders including MGUS, an abnormal protein known as the monoclonal protein (M protein) is present in the blood. Sometimes referred to as myeloma protein, this protein forms within the bone marrow — the blood-producing tissue in the center of most bones. Scientists have not determined what causes the protein to form, and many individuals who have MGUS don’t experience any signs or symptoms. MGUS can progress to multiple myeloma but does so at a very low rate.

If MGUS can go entirely undetected, how are individuals diagnosed with it? More importantly, if most people don’t show signs or symptoms, what does it mean if you do, and what symptoms might you experience? Here, we will take a look at the relationship between MGUS and PN, including how the two can be treated together.

What Is MGUS?

There is a spectrum of clonal plasma disorders referred to as monoclonal gammopathies. They include MGUS, multiple myeloma, and Waldenstrom’s macroglobulinemia. All of these disorders are characterized by the production of M protein, a type of monoclonal immunoglobulin. The term “monoclonal immunoglobulin” refers to antibodies that are exactly the same.

M protein is present in the blood of roughly 3 percent of the general population over the age of 50. This incidence increases with age, making it relatively common. Fortunately, very few people have a malignant form, such as multiple myeloma or Waldenstrom’s macroglobulinemia.

MGUS is considered premalignant, or benign, and is the most commonly diagnosed of the disorders. However, some forms of MGUS can become malignant (cancerous). The three major types of MGUS — IgM MGUS, non-IgM MGUS, and light-chain MGUS — are associated with different types of malignancy. IgM MGUS can progress to Waldenstrom’s macroglobulinemia; non-IgM MGUS can progress to multiple myeloma; and light-chain MGUS can progress to a light-chain type of multiple myeloma. According to a long-term study from 2002, MGUS has a very small chance — 1 percent per year — of developing into one of the malignant forms.

What Is Peripheral Neuropathy?

Peripheral neuropathy is the name for any condition that involves damage to the peripheral nervous system. This large communication network sends signals between the brain and spinal cord (the central nervous system) and other parts of the body. The nerves responsible for sending the signals, known as the peripheral nerves, serve many functions, including:

  • Telling the muscles to move
  • Helping control areas in the body such as the heart and blood vessels
  • Controlling functions like digestion and urination
  • Informing the body when your hands or feet are cold

The peripheral nerves are essential to keeping the body functioning normally. When these nerves are damaged, peripheral neuropathy is the result. Peripheral neuropathy can present with many neurological symptoms, including:

  • Numbness
  • Weakness
  • Pain
  • Tingling (or pins-and-needles feeling) in the hands, feet, or other areas of the body

What Does Peripheral Neuropathy Feel Like?

PN’s impact on a person’s life depends on its severity. Some individuals experience tingling in a limited area of the body, and it does not hinder them from remaining active. In the most severe cases, however, individuals with PN cannot walk at all because of the intense pain their neuropathy causes.

Individuals with MGUS face symptoms including numbness, balance issues, or tingling in their hands or feet, which often feels like pins and needles. This sensation results from peripheral neuropathy and is often the first indication that something is wrong.

Many members of MyMyelomaTeam share their experiences with peripheral neuropathy. One member wrote, “My first symptom of MGUS was numbness in my toes. My neuropathy spread from my feet to the top of my hips. I was so weak I ended up in a wheelchair. I walked with a walker or a cane for several years.”

Weakness is another common symptom of peripheral neuropathy discussed by members of the MyMyelomaTeam community. One wrote about leg weakness, saying, “The neuropathy weakens my legs and gives me pins-and-needles pain down both of my legs.”

Another member's experience with peripheral neuropathy negatively impacted more than just their physical health: “Peripheral neuropathy is the worst part for me. I was a runner and biker for years, but have had to give it up.”

Peripheral Neuropathy and MGUS

A MGUS diagnosis can occur by chance, so many individuals present with peripheral neuropathy before being diagnosed with MGUS. Until the cause of the neuropathy is revealed, the condition is referred to as unexplained neuropathy.

Peripheral neuropathy is a well-recognized complication of clonal plasma disorders. If you exhibit the common risk factors for the presence of the M protein, your doctor likely will test your blood for it. Deciphering the exact cause of PN, however, might take some time: A doctor will need to rule out the possibility of multiple myeloma, Waldenstrom’s macroglobulinemia, and other plasma cell disorders — such as immunoglobulin light-chain amyloidosis and osteosclerotic myeloma. A doctor will perform certain tests to determine which monoclonal gammopathy is to blame for peripheral neuropathy.

A person living with MGUS can be expected to develop peripheral neuropathy. That said, having PN does not necessarily indicate a more severe health issue. PN can have many different causes, and it’s necessarily an indication of disease progression, especially in MGUS.

Detecting MGUS

MGUS typically causes no symptoms, so detection of the condition usually happens by chance when a person’s blood is tested for other reasons. A blood test may show an increased total protein, for example. From there, a more specific blood test, known as serum electrophoresis, can identify the particular abnormality present. A doctor may order a blood test for people who are experiencing symptoms with no known cause.

Treating Peripheral Neuropathy From MGUS

A person’s PN treatment plan will depend on certain factors. If the condition causing the peripheral neuropathy can be treated (such as multiple myeloma or Waldenstrom’s macroglobulinemia), then symptoms will likely ease as the condition does.

MGUS, on the other hand, typically is not treated. Instead, MGUS is carefully monitored to make sure the condition is not progressing to a malignant form.

Certain symptoms or complications caused by MGUS can be treated, however. If a person experiences severe PN, a doctor may prescribe medication. For people with the IgM type of MGUS, intravenous immunoglobulin treatments may offer short-term relief. Unfortunately, regardless of a person’s MGUS type, there is no certainty that any current treatment will work.

If you have peripheral neuropathy from MGUS, you should ask a neurology specialist what treatment options are available for you. It is also important to attend follow-up appointments with your health care team to monitor the progression of your condition and symptoms.

Find Your Community

MyMyelomaTeam is the social network for people with myeloma and their loved ones. Here, a community of individuals comes together to share their experiences and encouragement with others. Members frequently discuss MGUS and neuropathy pain.

Have you experienced MGUS or peripheral neuropathy with myeloma? Share your experience in the comments below or by posting on MyMyelomaTeam.

All updates must be accompanied by text or a picture.
Mark Levin, M.D. is a hematology and oncology specialist with over 37 years of experience in internal medicine. Review provided by VeriMed Healthcare Network. Learn more about him here.
Samantha Poorman is a freelance writer. She is a graduate of Eastern Illinois University, where she taught composition courses. Learn more about her here.

Related articles

Feelings of worry, fear, and anxiety are common when living with cancer such as myeloma. In fact,...

Managing Anxiety and Myeloma

Feelings of worry, fear, and anxiety are common when living with cancer such as myeloma. In fact,...
Many MyMyelomaTeam members experience sleep problems, including insomnia. There may be different...

Insomnia and Multiple Myeloma: Managing Sleep Problems

Many MyMyelomaTeam members experience sleep problems, including insomnia. There may be different...
Multiple myeloma is cancer that forms in plasma cells (a type of white blood cell that is part of...

Managing Nausea and Multiple Myeloma

Multiple myeloma is cancer that forms in plasma cells (a type of white blood cell that is part of...
For many people diagnosed with multiple myeloma, weight loss was one of the first signs that...

Weight Changes and Myeloma

For many people diagnosed with multiple myeloma, weight loss was one of the first signs that...
Shortness of breath, also called dyspnea, is a common symptom of multiple myeloma, a type of...

Breathing Problems and Multiple Myeloma

Shortness of breath, also called dyspnea, is a common symptom of multiple myeloma, a type of...
People living with multiple myeloma often experience dizziness. For some MyMyelomaTeam members,...

Dizziness and Multiple Myeloma

People living with multiple myeloma often experience dizziness. For some MyMyelomaTeam members,...

Recent articles

Every myeloma therapy option comes with potential benefits and potential risks.Your doctor will...

Weighing the Risks and Benefits of Myeloma Treatment Options

Every myeloma therapy option comes with potential benefits and potential risks.Your doctor will...
Working while undergoing treatment for multiple myeloma is a personal decision with several...

Working With Multiple Myeloma

Working while undergoing treatment for multiple myeloma is a personal decision with several...
Thanks to years of cancer research and public-health messaging, most people understand that...

Smoking and Multiple Myeloma

Thanks to years of cancer research and public-health messaging, most people understand that...
Around 63 percent of people newly diagnosed with myeloma are also living with — or have a history...

Understanding Heart Disease and Myeloma Treatment

Around 63 percent of people newly diagnosed with myeloma are also living with — or have a history...
Multiple myeloma is a cancer in which white blood cells called plasma cells develop abnormalities...

Myeloma and Ethnicity: Is Race a Risk Factor in Multiple Myeloma?

Multiple myeloma is a cancer in which white blood cells called plasma cells develop abnormalities...
People with multiple myeloma at any stage can benefit from palliative care. This type of care can...

Palliative Care: Improving Quality of Life With Myeloma at Any Stage

People with multiple myeloma at any stage can benefit from palliative care. This type of care can...
MyMyelomaTeam My myeloma Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close